Aigen Investment Management LP Takes $2.76 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Aigen Investment Management LP purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNH) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 4,725 shares of the healthcare conglomerate’s stock, valued at approximately $2,763,000. UnitedHealth Group comprises approximately 0.5% of Aigen Investment Management LP’s investment portfolio, making the stock its 27th largest holding.

A number of other hedge funds and other institutional investors have also recently modified their holdings of UNH. Tealwood Asset Management Inc. bought a new position in UnitedHealth Group in the 3rd quarter valued at approximately $2,905,000. Asset Planning Services Inc. LA ADV grew its stake in shares of UnitedHealth Group by 1.2% in the third quarter. Asset Planning Services Inc. LA ADV now owns 12,465 shares of the healthcare conglomerate’s stock worth $7,288,000 after purchasing an additional 150 shares during the last quarter. Sequoia Financial Advisors LLC grew its position in shares of UnitedHealth Group by 13.7% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 24,976 shares of the healthcare conglomerate’s stock valued at $14,603,000 after buying an additional 3,006 shares during the last quarter. Americana Partners LLC increased its position in UnitedHealth Group by 10.8% during the 3rd quarter. Americana Partners LLC now owns 20,377 shares of the healthcare conglomerate’s stock valued at $11,914,000 after purchasing an additional 1,984 shares during the period. Finally, Hennion & Walsh Asset Management Inc. boosted its stake in shares of UnitedHealth Group by 14.8% in the 2nd quarter. Hennion & Walsh Asset Management Inc. now owns 9,960 shares of the healthcare conglomerate’s stock valued at $5,072,000 after purchasing an additional 1,283 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 1.3 %

UNH traded down $8.25 during trading on Tuesday, reaching $617.00. The stock had a trading volume of 439,396 shares, compared to its average volume of 3,885,649. The company has a current ratio of 0.91, a quick ratio of 0.88 and a debt-to-equity ratio of 0.74. The stock’s 50 day moving average is $582.63 and its two-hundred day moving average is $546.78. The company has a market capitalization of $567.82 billion, a price-to-earnings ratio of 40.73, a P/E/G ratio of 1.81 and a beta of 0.58. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. UnitedHealth Group’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $6.56 EPS. As a group, analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.36%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group’s payout ratio is currently 54.72%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on UNH shares. StockNews.com lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 24th. Jefferies Financial Group upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and raised their price target for the stock from $481.00 to $647.00 in a report on Wednesday, July 17th. Barclays decreased their price target on shares of UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating for the company in a research note on Tuesday, October 22nd. HSBC cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 17th. Finally, KeyCorp started coverage on shares of UnitedHealth Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $675.00 target price for the company. Four investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $615.53.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.